Literature DB >> 20491761

Treatment of pityriasis rubra pilaris with ustekinumab.

J Wohlrab, B Kreft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20491761     DOI： 10.1111/j.1365-2133.2010.09855.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  17 in total

1.  [Pityriasis rubra pilaris].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2012-08       Impact factor: 0.751

Review 2.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

3.  Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra Pilaris: A Case Series of 100 Patients.

Authors:  Nicholas A Ross; Hye-Jin Chung; Qiaoli Li; Jonathan P Andrews; Matthew S Keller; Jouni Uitto
Journal:  JAMA Dermatol       Date:  2016-06-01       Impact factor: 10.282

Review 4.  New developments in the molecular treatment of ichthyosis: review of the literature.

Authors:  M D W Joosten; J M K Clabbers; N Jonca; J Mazereeuw-Hautier; A H Gostyński
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

5.  Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

Authors:  Alessandro Di Stefani; Marco Galluzzo; Marina Talamonti; Andrea Chiricozzi; Antonio Costanzo; Sergio Chimenti
Journal:  J Dermatol Case Rep       Date:  2013-03-30

6.  Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris.

Authors:  Mudit Chowdhary; Ulysses Davila; David J Cohen
Journal:  Case Rep Dermatol       Date:  2015-03-17

Review 7.  Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis.

Authors:  Laura J Savage; Miriam Wittmann; Dennis McGonagle; Philip S Helliwell
Journal:  Rheumatol Ther       Date:  2015-03-17

8.  CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.

Authors:  Brittany G Craiglow; Lynn M Boyden; Ronghua Hu; Marie Virtanen; John Su; Gabriela Rodriguez; Catherine McCarthy; Paula Luna; Margarita Larralde; Stephen Humphrey; Kristen E Holland; Marcia Hogeling; Benjamin Hidalgo-Matlock; Bruno Ferrari; Esteban Fernandez-Faith; Beth Drolet; Kelly M Cordoro; Anne M Bowcock; Richard J Antaya; Kurt Ashack; Richard J Ashack; Richard P Lifton; Leonard M Milstone; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2018-03-01       Impact factor: 11.527

Review 9.  Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Authors:  Sahil Rawal; Sara Kianian; William Guo; Jocellie Marquez; Marissa Ayasse; Katherine A Siamas; Yoojin Lee; Joann Salvemini
Journal:  Arch Dermatol Res       Date:  2021-06-22       Impact factor: 3.017

10.  Biologics in dermatology.

Authors:  David Chandler; Anthony Bewley
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.